OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
OCX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific Inc.
-0.34%230.011.0%$371.70m
ISRGIntuitive Surgical, Inc.
0.20%524.922.4%$370.22m
MDTMedtronic PLC
-0.59%90.560.6%$368.91m
ALGNAlign Technology, Inc.
1.74%357.306.3%$295.74m
ABTAbbott Laboratories
0.86%64.710.8%$290.10m
ABMDABIOMED, Inc.
-2.75%358.823.3%$250.70m
BSXBoston Scientific Corporation
0.38%34.421.1%$244.85m
BDXBecton, Dickinson and Company
0.16%253.041.1%$238.44m
BAXBaxter International Inc.
0.62%72.021.7%$228.12m
SYKStryker Corporation
0.77%169.991.3%$220.63m
EWEdwards Lifesciences Corporation
0.24%139.721.2%$187.71m
DXCMDexCom, Inc.
2.07%130.968.6%$162.53m
ZBHZimmer Biomet Holdings, Inc.
0.89%123.851.7%$147.94m
XRAYDENTSPLY International Inc.
1.55%38.673.0%$137.13m
IDXXIDEXX Laboratories, Inc.
0.10%243.503.7%$108.59m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.